thc
POTOMAC, Md., December 02, 2021–(BUSINESS WIRE)–(NYSE American: IGC), India Globalization Capital, Inc. (IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The investigational new drug, IGC-AD1, is IGC’s proprietary Tetrahydrocannabinol (THC)-based candidate designed to treat certain symptoms of Alzheimer’s disease. The results of the clinical […]
GREENWOOD VILLAGE, CO, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Pure Harvest Corporate Group, Inc. (OTCQB: PHCG), a vertically integrated consumer products holding company focused on cutting edge plant-based nutraceuticals, recreational cannabis, hemp-derived health and wellness products, and other emerging industries, is excited to issue an open letter to shareholders from its CEO, Matthew Gregarek. Dear […]
WestCann: A Unique Business Model with Plenty of Catalysts Ahead
The legal cannabis industry has grown from humble beginnings in the early 2000s into a multi-billion dollar global industry. In addition to THC-containing products capturing market share from the black market, CBD and other cannabinoids have exploded onto the health and wellness scene as researchers continue to uncover potential benefits. Of course, a license to […]
Agra Ventures Subsidiary Farmako Launches New THC and CBD Testkit to German Pharmacies
The Proprietary Testkits Perform Identity Testing of Both THC and CBD in Cannabis Products VANCOUVER, British Columbia, Oct. 14, 2021 (GLOBE NEWSWIRE) — Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (Frankfurt: PU30) (OTCPK: AGFAF), a growth-oriented and diversified company focused on the international cannabis industry, is pleased to announce that its wholly owned subsidiary, Farmako GmbH (“Farmako”), has expanded its portfolio of cannabis […]
Skye Bioscience Completes THCVHS IND-enabling In Vitro Genotoxicity Studies
THCVHS shows no signs of chromosomal or gene mutations in preclinical studies SAN DIEGO, CA, Aug. 10, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet need, has successfully completed genotoxicity studies of THCVHS required prior to beginning its planned […]
BC Craft Supply Co Announces Provision Patent for Custom Cannabis Micro-Dosing Tablet Dispenser
VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) — BC Craft Supply Co Ltd., (CSE: CRFT) (“CRFT” or the “Company”), a diversified wellness company advancing cannabinoid and psychedelic innovation and psychotherapy, is pleased to announce that its subsidiary, FeelWell Brands Inc. (“FeelWell”) has filed a provisional patent application in the United States Patent and Trademark […]
Data Analysis Yields Insights Into Medical Cannabis Use, Efficacy
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. Every major professional sport is undergoing an analytics revolution. Pharmaceutical companies use artificial intelligence (AI) to […]
OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company, (BRC), an active Drug Enforcement Administration (DEA) license holder, to produce federally-compliant cannabis-based medical products. Currently, CURE uses its Schedule 1 DEA license for the development […]
Ovation Science’s Proven Science, IP, and Royalty Model Protects Investors and the Company
If a company has developed very effective, transformative technology, it takes an investment into research and development and time. It also pays to protect it from copycats and pirates with patents. And if the company’s specialty is science and product development rather than in retail sales and marketing, a royalty- or license-based revenue model could […]
Dispensaries Can Boost Cannabis Sales with Unique Topical Products
As the legal cannabis industry matures and expands, the goal of many companies is (and should be) to reach people who might not historically be cannabis consumers. According to a 2020 Gallup poll, about 12% of US adults say they smoke marijuana. This percentage has remained fairly steady over the past several years, even […]
Ovation: Where Science, Medicine, and Cannabis Meet
With the quickly expanding legal cannabis market finding its legs after years of prohibition, there are several hurdles remaining before the plant and its cannabis-derived product offspring are fully accepted by mainstream society. First and foremost is, of course, full legalization. From that important step everything follows, from banking regulations to changes in incarceration […]
Patents in the Cannabis Industry: Increased Investor Protection
In any emerging industry, patent protection becomes a key component. The ability to exclusively produce and profit off of one’s own innovation encourages research, development, and investment. Many companies’ valuations are based in a large part on the extent to which their intellectual property is protected. The cannabis industry offers some hurdles to achieving that […]
Vancouver, British Columbia, April 19, 2021: Cannabix Technologies Inc.(CSE: BLO, OTC PINK: BLOZF) (the “Company”) developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, reports that it has received a notice of allowance from the Canadian Intellectual Property Office (CIPO) for its 2015 licensed patent application, No. 2887841 entitled, “Cannabis Drug Detection Device”. The Company […]
VANCOUVER, British Columbia, JANUARY 13, 2021 Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that it is beginning to produce ultra-high potency cannabis distillate oils from its 32,500 kg / 71,650 lb harvest of sun-grown cannabis cultivated during the Company’s inaugural growing season, which can […]
SinglePoint and Convectium: Investing in Cannabis Packaging Speed
The negative stigmas attached to cannabis continue to fade away like a puff of smoke in the wind. Most people are now well aware of the therapeutic benefits of the cannabis plant and its cousin hemp. Investors are certainly aware of the massive industry unfolding. Against this backdrop, cannabis operations have moved from the […]
Hemptown Poised to Profit Following Passage of US Farm Bill
Hemptown Poised to Profit Following Passage of US Farm Bill Prior to the 2018 US Farm Bill, hemp – defined by the legislation as the cannabis plant containing less than 0.3% THC – carried the same legal classification as THC-rich cannabis, and aside from a handful of pilot projects, the mass production of industrial […]
ICC Expanding to New Zealand with NUBU Supply Agreement
Although the possession of any amount of cannabis has been illegal in New Zealand since 1975, half of the population aged 17-65 admit to trying cannabis, while one in six report being regular users, giving the country the ninth-highest cannabis consumption level in the world. In December of last year, the Misuse of […]
Weekend Unlimited Sets Sights on Washington State; Plus Exclusive Interview With CEO Chris Backus
Many multi-state operators choose to focus the bulk of their initial efforts in one market, then take what they’ve learned there, and replicate their successes in other states. Lifestyle Brand Weekend Unlimited (CSE: POT, FSE: 0OS1, OTCQB: WKULF) has chosen Washington as its target market, guided by an understanding that its cannabis industry is far […]
The Global Big Data Market Meets RYAH Medtech’s Unique Vaporizer
The output of analyzing large blocks of information, or “big data” as it is generally known, to identify trends is one of the most valuable commodities today. One of the beauties of big data is that it can pinpoint trends at all scales, from an individual to an entire country. Another is that it […]
Exclusive Interview with Wildflower Brands CEO: Health and Wellness Cannabis Products
Wildflower Brands (CSE: SUN, OTC: WLDFF) is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of the company’s brands work in synergy toward becoming a global wellness leader. Wildflower distributes products across North America through the regulated cannabis markets as well as through nutraceutical channels, and the […]
From Smoking to Munching; Indiva Prepared for Cannabis 2.0 Revolution
The legalization of cannabis in Canada on October 17, 2018 was seen as a progressive and forward-thinking development.It put Canada at the forefront of this exciting new industry, as the only country other than Uruguay to legalize cannabis on a federal level. However as dynamic as this legislation was, it was limited in terms of […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Lexaria Corp is an aspiring producer of medical marijuana under Canada’s Marihuana for Medical Purposes Regulations (“MMPR”). On March 5, 2014, the company signed a joint venture with Enertopia Corp. (OTC: ENRT) (CSE: TOP) with the goal of bringing a 60,000 square foot cultivation facility online.
Hempsana Inc. is a Canadian cannabis company specializing in cannabis derivatives with focus on Extraction & Purification, End-Product Manufacturing and Testing.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
